Reliv' International, Inc. (RELV) Forms $4.64 Double Bottom; Cello Group Plc (LON:CLL) Covered By 4 Bulls

April 23, 2018 - By Annabelle Johnson

Cello Group Plc (LON:CLL) Logo

Reliv' International, Inc. (RELV) formed double bottom with $4.41 target or 5.00% below today’s $4.64 share price. Reliv' International, Inc. (RELV) has $8.56 million valuation. The stock decreased 0.85% or $0.04 during the last trading session, reaching $4.64. About 11,706 shares traded. Reliv' International, Inc. (NASDAQ:RELV) has declined 0.80% since April 23, 2017 and is downtrending. It has underperformed by 12.35% the S&P500.

Among 4 analysts covering Cello Group (LON:CLL), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cello Group had 34 analyst reports since September 16, 2015 according to SRatingsIntel. FinnCap maintained it with “Buy” rating and GBX 132 target in Monday, October 3 report. N+1 Singer maintained it with “Buy” rating and GBX 131 target in Wednesday, September 20 report. The company was maintained on Thursday, November 17 by FinnCap. The rating was maintained by Peel Hunt with “Buy” on Thursday, June 23. Peel Hunt maintained the shares of CLL in report on Thursday, February 11 with “Buy” rating. The rating was maintained by FinnCap with “Buy” on Monday, June 19. On Tuesday, September 20 the stock rating was maintained by N+1 Singer with “Buy”. The firm earned “Buy” rating on Wednesday, March 22 by N+1 Singer. The company was maintained on Tuesday, May 9 by FinnCap. FinnCap maintained the stock with “Buy” rating in Wednesday, September 20 report. See Cello Group Plc (LON:CLL) latest ratings:

22/03/2018 Broker: FinnCap Rating: Corporate Old Target: GBX 135.00 New Target: GBX 145.00 Maintain
04/12/2017 Broker: FinnCap Rating: Buy Old Target: GBX 135.00 New Target: GBX 135.00 Maintain

Cello Group plc, together with its subsidiaries, provides marketing services in the United Kingdom, Rest of Europe, the United States, and internationally. The company has market cap of 124.96 million GBP. It operates in two divisions, Cello Health and Cello Signal. It has a 29.88 P/E ratio. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients.

The stock increased 0.42% or GBX 0.5 during the last trading session, reaching GBX 119.5. About 48,778 shares traded. Cello Group Plc (LON:CLL) has 0.00% since April 23, 2017 and is . It has underperformed by 11.55% the S&P500.